Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 99-105

  Pompili, Cecilia ^a   Brunelli, Alessandro ^a   Xiumé, Francesco ^a   Refai, Majed ^a   Salati, Michele ^a   Socci, Laura ^a   Di Nunzio, Luca ^a   Sabbatini, Armando ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

EORTC; Pulmonary resection; Quality of life; SF 36

Indexed keywords

CARBON MONOXIDE;

AGED; ALOPECIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; COGNITION; CONSTIPATION; COUGHING; DIARRHEA; DYSPHAGIA; DYSPNEA; EMOTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HUMAN; INSOMNIA; LUNG CAPACITY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MENTAL HEALTH; MOUTH PAIN; NAUSEA AND VOMITING; PAIN; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 36; SHOULDER PAIN; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; THORAX PAIN;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROSPECTIVE STUDIES; PSYCHOMETRICS; PULMONARY DIFFUSING CAPACITY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 79958014501     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.10.026     Document Type: Article

References (23)

1. Johnson J.R., Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985, 69:1155-1159.
2. Parkerson G.R., Broadhead W.E., Chiu-Kit J. The Duke Health profile. Med Care 1990, 28:1062-1072.
3. Hays R.D. Generic versus disease-targeted instruments. Assessing quality of life in clinical trials 2005, 3-8. Oxford University Publishers, New York, NY. 2nd ed. P. Fayers, R. Hays (Eds.).
4. Ware J.E., Sherbourn C.D. The MOS 36-items short form health survey (SF36): I. Conceptual frameworks and items selection. Med Care 1992, 30:473-483.
5. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Flechtner H., Fleishman S.B., de Haes J.C.J.M., Kaasa S., Klee M.C., Osoba D., Razavi D., Rofe P.B., Schraub S., Sneeuw K.C.A., Sullivan M., Takeda F. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
6. Kuenster S., Langelotz C., Budach V., Possinger K., Krause B., Sezer O. The comparability of quality of life scores: a multitrait method analysis of EORTC QLQ-C30, SF-36 and FLIC questionnaires. Eur J Cancer 2002, 38:339-348.
7. Apolone G., Filiberti A., Cifani S., Ruggiata R., Mosconi P. Evaluation of the EORTC QLQ C-30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998, 9:549-557.
8. Porzsolt F., Wolpl C., Rist C.E., Kosa R., Buchele G., Gaus W. Comparison of three instruments (QLQ-C30, SF-36, QWB-7) measuring health-related quality of life/quality of well-being. Psycho-Oncology 1996, 5:103-117.
9. Fredheim O.M., Borchgrevink P.C., Saltnes T., Kaasa S. Validation and comparison of the health related quality of life instruments EORTC QLQ C-30 and SF-36 in assessment of patients with chronic nonmalignant pain. J Pain Symptom Man 2007, 34:657-665.
10. Cerfolio R.J., Bryant A.S., Maniscalco L.M. A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomized trial. Ann Thorac Surg 2008, 85:1901-1907.
11. McHorney C.A., Ware J.E., Lu J.F., Sherbourn C.D. The MOS 36-items short form health survey (SF-36): III. Test of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66.
12. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A The EORTC QLQ-C30 Scoring Manual 2001, on behalf of the EORTC Quality of Life Group, European Organisation for Research and Treatment of Cancer, Brussels. 3rd edition.
13. Cohen J. Statistical power for the behavioral sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ. 2nd edition.
14. Valentine J.C., Cooper H. Effect size substantive interpretation guidelines: issues in the interpretation of effect sizes 2003, What Works Clearinghouse, Washington, DC.
15. Wiebe S., Guyatt G., Weaver B., Matijevic S., Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003, 56:52-60.
16. Brazier J.E., Harper R., Jones N.M., O'Cathain A., Thomas K.J., Usherwood T., Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992, 305(6846):160-164.
17. Stewart A.L., Hays R.D., Ware J.E. The MOS short form general health survey: reliability and validity in a patient population. Med Care 1988, 26:724-735.
18. Shipper H., Clinch J., McMurray J., Levitt M. Measuring the quality of life cancer patients. The Functional Living Index-Cancer. Development and validation. J Clin Oncol 1984, 2:472-483.
19. Ganz P.A., Schang C., Lee J.J., Sim M. The CARES: a generic measure of health related quality of life for patients with cancer. Qual Life Res 1992, 1:19-29.
20. Cella D., Tulsky D.S., Gray G. The Functional Assessment of Cancer Therapy (FACT) Scale: development and validation of the general measure. J Clin Oncol 1993, 11:570-579.
21. Paull D.E., Thomas M.L., Meade G.E., Updyke G.M., Arocho M.A., Chin H.W., Adebonojo S.A., Little A.G. Determinants of quality of life in patients following pulmonary resection for lung cancer. Am J Surg 2006, 192:565-571.
22. Balduyck B., Hendriks J., Lauwers P., Van Schil P. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer 2007, 56:423-431.
23. Schulte T., Schniewind B., Dohrmann P., Küchler T., Kurdow R. The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer. Chest 2009, 135:322-329.